Roku (NASDAQ:ROKU) is still a growth stock, despite the fact that it’s been falling lately. In fact, in my last article on ROKU stock, I wrote that it could end up falling some 20% to 30% from Aug. 11. That was when it was at $369.21. Since then, it has fallen 9%.
Snowflake (NYSE:SNOW) pioneered the data cloud, a platform that helps clients manage and make sense of big data. Of course, data is knowledge and knowledge is power, but that’s only true if you have the tools to harness data and unlock its value. And that’s become increasingly difficult as enterprises are generating data at a phenomenal pace. So Snowflake attempts to solve a critical problem.
In a somewhat surprising move, Warren Buffett’s Berkshire Hathaway invested $735 million in this high-growth tech stock around the time of its initial public offering last September.....More>>>
The past year-plus has been easy going for investors looking to generate profits from equity returns, with the S&P 500 up by almost double from the March 2020 lows. Income, however, is another story altogether. Already-low interest rates started retreating this sprin
Regeneron Pharmaceuticals (REGN Quick QuoteREGN ) and Eli Lilly & Company (LLY Quick QuoteLLY ) announced new agreements with the U.S. government to supply additional doses of their respective COVID-19 antibody drugs amid greater demand due to the rising infection rates in the
Core Alternative Capital boosted its holdings in Merck & Co., Inc. (NYSE:MRK – Get Rating) by 21.4% in the second quarter, Holdings Channel reports. The firm owned 94,064 shares of the company's stock after purchasing an additional 16,574 shares during the quarter. Merck & C
Regeneron Pharmaceuticals, Inc. (REGN Quick QuoteREGN ) announced that the U.K.’s Medicines and Healthcare products Regulatory Agency (“MHRA”) has granted Conditional Marketing Authorization (CMA) to its antibody cocktail, casirivimab and imdevimab, to prevent and tre